Literature DB >> 11809537

The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus.

Yoshihiro Nakakubo1, Yasuhiro Hida, Masaki Miyamoto, Hideaki Hashida, Taro Oshikiri, Kentaro Kato, Masato Suzuoki, Kei Hiraoka, Tomoo Ito, Toshiaki Morikawa, Shunichi Okushiba, Satoshi Kondo, Hiroyuki Katoh.   

Abstract

Overexpression of RCAS1 (receptor-binding cancer antigen expressed on SiSo cells) protects cancer cells from immune attack and might be related to poor prognosis in several cancers. We investigated the immunoreactivity of RCAS1 and its correlation with clinicopathological features in 95 patients who underwent surgical resection for oesophageal squamous cell carcinoma. Thirty-two of the 95 (33.7%) cases were strongly positive for RCAS1. RCAS1 showed significant correlations with age and stage grouping. Expression of RCAS1 was associated with shorter postoperative survival. Multivariate analysis indicated that RCAS1 positivity was an independent negative prognostic factor. Our study establishes RCAS1 as a novel prognostic marker for surgically resected oesophageal squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809537     DOI: 10.1016/s0304-3835(01)00773-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma.

Authors:  Shunichi Tsujitani; Hiroaki Saito; Shinichi Oka; Teruhisa Sakamoto; Shingo Kanaji; Shigeru Tatebe; Masahide Ikeguchi
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

2.  The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers.

Authors:  Sahin Coban; Hasan Ozkan; Seyfettin Köklü; Osman Yüksel; Muhammed Cem Koçkar; Tarik Akar; Necati Ormeci
Journal:  Can J Gastroenterol       Date:  2006-09       Impact factor: 3.522

3.  Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer.

Authors:  K Leelawat; T Watanabe; M Nakajima; S Tujinda; C Suthipintawong; V Leardkamolkarn
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

4.  Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesions.

Authors:  Constantinos Giaginis; Nikoleta Demetriou; Paraskevi Alexandrou; Vasileios Stolakis; Ioanna Delladetsima; Jerzy Klijanienko; Ioannis Griniatsos; Stamatios Theocharis
Journal:  Med Sci Monit       Date:  2012-04

5.  RCAS1 expression in mobile tongue squamous cell carcinoma: an immunohistochemical study.

Authors:  Stamatios Theocharis; Jerzy Klijanienko; Constantinos Giaginis; Jose Rodriguez; Thomas Jouffroy; Angelique Girod; Gerasimos Tsourouflis; Xavier Sastre-Garau
Journal:  Med Sci Monit       Date:  2011-08

6.  Expression of RCAS1 correlates with urothelial bladder cancer malignancy.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2015-02-10       Impact factor: 5.923

7.  The association between RCAS1 expression in laryngeal and pharyngeal cancer and its healthy stroma with cancer relapse.

Authors:  Magdalena Dutsch-Wicherek; Romana Tomaszewska; Agata Lazar; Lukasz Wicherek; Jacek Skladzien
Journal:  BMC Cancer       Date:  2009-01-28       Impact factor: 4.430

Review 8.  Cancer therapy using tumor-associated antigens to reduce side effects.

Authors:  David Siu
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 5.057

9.  Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.

Authors:  J-I Akahira; M Aoki; T Suzuki; T Moriya; H Niikura; K Ito; S Inoue; K Okamura; H Sasano; N Yaegashi
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

10.  Increased RCAS1 expression is associated with advanced histopathological stage and poor prognosis in patients with gastric adenocarcinoma.

Authors:  Constantinos Giaginis; Themistoclis Efkarpidis; Paraskevi Alexandrou; Efstratios Patsouris; Gregory Kouraklis; Stamatios Theocharis
Journal:  Dis Markers       Date:  2013-09-03       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.